July 29 (Reuters) - Laboratorio Reig Jofre SA RJFE.MC :
* H1 NET PROFIT 3.6 MILLION EUROS VERSUS 3.9 MILLION EUROS
YEAR
AGO
* H1 TURNOVER 116.1 MILLION EUROS VERSUS 115.8 MILLION EUROS
YEAR
AGO
* H1 EBITDA 13.3 MILLION EUROS VERSUS 13.0 MILLION EUROS
YEAR AGO
* SAYS NEW PLANT WILL START UP IN SECOND HALF OF YEAR,
HELPING TO
IMPROVE PHARMACEUTICAL TECHNOLOGIES DIVISION'S REVENUES IN 2021
* TECHNOLOGY TRANSFER AGREEMENT FOR THE COVID-19 VACCINE
WILL BE
COMPLETED IN THE SECOND HALF OF 2021
* ONCE PROCESS IS COMPLETED, JANSSEN TO DEFINE THE SUPPLY
NEEDS IT
WILL REQUIRE FROM REIG JOFRE, WITHIN ITS GLOBAL VACCINE SUPPLY
NETWORK
Source text for Eikon: ID:nCNMBRN1t
Further company coverage: RJFE.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))